logo image

Voglibose information from DrugsUpdate  

See Available Brands of Voglibose in India

P - Contraindicated in pregnancy
L - Contraindicated in lactation

Voglibose, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus.



Voligbose has general properties similar to acarbose and selectively inhibits α-glucosidase in the enteric canal, delaying the digestion and absorption of carbohydrate, thereby suppressing sharp increase in post-prandial plasma glucose.

Voglibose Indications / Voglibose Uses

Information Not Available

Voglibose Adverse Reactions / Voglibose Side Effects

Flatulence; abdominal distension; diarrhoea; pain; skin reactions; hypoglycemia; increased LFT.

Potentially Fatal: Hepatotoxicity.


Information Not Available

Special Precautions

History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 years; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).

Other Drug Interactions

May enhance effects of other antidiabetics including insulin.

Other Interactions

Information Not Available


Diabetes mellitus
Adult: 200-300 mcg tid.
Elderly: Initiate at lower doses.


Should be taken with food. (Take just before meals.)

List of Contraindications

Voglibose and Pregnancy

Contraindicated in pregnancy

Voglibose and Lactation

Contraindicated in lactation

Voglibose and Children

Information Not Available

Voglibose and Geriatic

Information Not Available

Voglibose and Other Contraindications

Inflammatory bowel disease; GI obstruction or patients predisposed to it; conditions which may deteriorate as a result of increased gas formation eg, hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation. Not to be used as monotherapy in IDDM.


Store below 30°C.

Lab interference

Store below 30°C.

© 2011-2018 DrugsUpdate.com. Disclaimer | Site Map